Practical recommendations for screening of information on the drug safety
Active development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attra...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
2018-02-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/52 |
id |
doaj-2fe145d68db34332b4155f97f53a50dc |
---|---|
record_format |
Article |
spelling |
doaj-2fe145d68db34332b4155f97f53a50dc2021-07-28T14:03:05ZrusFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation Безопасность и риск фармакотерапии2312-78212619-11642018-02-0103363952Practical recommendations for screening of information on the drug safetyE. Yu. Pasternak0T. M. Bukatina1R. N. Alyautdin2B. K. Romanov3Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsActive development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attracted to the problem of drug safety the attention of practitioners and other health professionals. This article presents practical recommendations on possible sources for screening of information on the drug safety, which can operate in their activity as health professionals.https://www.risksafety.ru/jour/article/view/52фармаконадзорлекарственное средствомониторинг безопасности лекарственных средствисточники информации о безопасности лекарственных препаратовpharmacovigilancedrugdrug safety monitoringinformational sources |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
E. Yu. Pasternak T. M. Bukatina R. N. Alyautdin B. K. Romanov |
spellingShingle |
E. Yu. Pasternak T. M. Bukatina R. N. Alyautdin B. K. Romanov Practical recommendations for screening of information on the drug safety Безопасность и риск фармакотерапии фармаконадзор лекарственное средство мониторинг безопасности лекарственных средств источники информации о безопасности лекарственных препаратов pharmacovigilance drug drug safety monitoring informational sources |
author_facet |
E. Yu. Pasternak T. M. Bukatina R. N. Alyautdin B. K. Romanov |
author_sort |
E. Yu. Pasternak |
title |
Practical recommendations for screening of information on the drug safety |
title_short |
Practical recommendations for screening of information on the drug safety |
title_full |
Practical recommendations for screening of information on the drug safety |
title_fullStr |
Practical recommendations for screening of information on the drug safety |
title_full_unstemmed |
Practical recommendations for screening of information on the drug safety |
title_sort |
practical recommendations for screening of information on the drug safety |
publisher |
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation |
series |
Безопасность и риск фармакотерапии |
issn |
2312-7821 2619-1164 |
publishDate |
2018-02-01 |
description |
Active development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attracted to the problem of drug safety the attention of practitioners and other health professionals. This article presents practical recommendations on possible sources for screening of information on the drug safety, which can operate in their activity as health professionals. |
topic |
фармаконадзор лекарственное средство мониторинг безопасности лекарственных средств источники информации о безопасности лекарственных препаратов pharmacovigilance drug drug safety monitoring informational sources |
url |
https://www.risksafety.ru/jour/article/view/52 |
work_keys_str_mv |
AT eyupasternak practicalrecommendationsforscreeningofinformationonthedrugsafety AT tmbukatina practicalrecommendationsforscreeningofinformationonthedrugsafety AT rnalyautdin practicalrecommendationsforscreeningofinformationonthedrugsafety AT bkromanov practicalrecommendationsforscreeningofinformationonthedrugsafety |
_version_ |
1721268780291588096 |